human placental hydrolysate

Human placental hydrolysate is a standardized, pharmaceutical-grade biological preparation derived from healthy human donor placentas. It is produced through enzymatic hydrolysis (typically using pepsin and hydrochloric acid) followed by rigorous sterilization and filtration processes to ensure safety and eliminate viral or bacterial pathogens. The resulting extract is a complex, chemically heterogeneous mixture containing low-molecular-weight peptides, amino acids, nucleotides, vitamins, minerals, and trace growth factors such as hepatocyte growth factor (HGF) and insulin-like growth factor 1 (IGF-1). It is widely utilized in East Asia and Russia for its hepatoprotective, immunomodulatory, anti-inflammatory, and tissue-regenerative properties. Standardized formulations are marketed under several brand names, including Laennec (approved for improving liver function in chronic liver disease) and Melsmon (approved for menopausal disorders and milk secretion deficiency). Additionally, it is investigated for various off-label and clinical-stage indications, including chronic fatigue syndrome, musculoskeletal pain, and neurodegenerative conditions such as multiple sclerosis.

Brand names

CuracenLaennecMelsmonPlagenticUnicenta

Other names

Hominis placenta extractHominis placenta hydrolysateHominis placental extractHominis placental hydrolysatehuman placenta extracthuman placental extractwater soluble human placental hydrolysate